ID   UKF-NB-3rCDDP1000
AC   CVCL_M478
SY   UKF-NB-3 CDDP
DR   Wikidata; Q54990334
RX   PubMed=16151587;
RX   PubMed=17505515;
RX   PubMed=22170099;
RX   PubMed=24466371;
RX   PubMed=27517323;
RX   PubMed=27735941;
RX   PubMed=31581737;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): PubMed=31581737
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 13
ST   D18S51: 16,18
ST   D19S433: 14
ST   D21S11: 29,33.2
ST   D2S1338: 16,21
ST   D3S1358: 15,18
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 9,10
ST   FGA: 19,25
ST   Penta D: 8,15
ST   Penta E: 12
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 15,18
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9904 ! UKF-NB-3
SX   Female
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
RX   PubMed=16151587;
RA   Bedrnicek, Jiri B.
RA   Vicha, Ales
RA   Jarosova, Marie
RA   Holzerova, Milena
RA   Cinatl, Jindrich Jr.
RA   Michaelis, Martin
RA   Cinatl, Jaroslaw
RA   Eckschlager, Tomas
RT   "Characterization of drug-resistant neuroblastoma cell lines by
RT   comparative genomic hybridization.";
RL   Neoplasma 52:415-419(2005).
//
RX   PubMed=27735941; DOI=10.1038/cddis.2016.257; PMCID=PMC5133961;
RA   Voges, Yvonne
RA   Michaelis, Martin
RA   Rothweiler, Florian
RA   Schaller, Torsten
RA   Schneider, Constanze
RA   Politt, Katharina
RA   Mernberger, Marco
RA   Nist, Andrea
RA   Stiewe, Thorsten
RA   Wass, Mark N.
RA   Rodel, Franz
RA   Cinatl, Jindrich Jr.
RT   "Effects of YM155 on survivin levels and viability in neuroblastoma
RT   cells with acquired drug resistance.";
RL   Cell Death Dis. 7:e2410.1-e2410.11(2016).
//
RX   PubMed=22170099; DOI=10.1038/cddis.2011.129; PMCID=PMC3252738;
RA   Michaelis, Martin
RA   Rothweiler, Florian
RA   Barth, Susanne
RA   Cinatl, Jaroslaw
RA   van Rikxoort, Marijke
RA   Loschmann, Nadine
RA   Voges, Yvonne
RA   Breitling, Rainer
RA   von Deimling, Andreas
RA   Rodel, Franz
RA   Weber, Kristoffer
RA   Fehse, Boris
RA   Mack, Elisabeth
RA   Stiewe, Thorsten
RA   Doerr, Hans-Wilhelm
RA   Speidel, Daniel
RA   Cinatl, Jindrich Jr.
RT   "Adaptation of cancer cells from different entities to the MDM2
RT   inhibitor nutlin-3 results in the emergence of p53-mutated
RT   multi-drug-resistant cancer cells.";
RL   Cell Death Dis. 2:e243.1-e243.8(2011).
//
RX   PubMed=17505515; DOI=10.1038/sj.bjc.6603777; PMCID=PMC2359931;
RA   Blaheta, Roman A.
RA   Michaelis, Martin
RA   Natsheh, Iyad
RA   Hasenberg, Christoph
RA   Weich, Eva
RA   Relja, Borna
RA   Jonas, Dietger
RA   Doerr, Hans-Wilhelm
RA   Cinatl, Jindrich Jr.
RT   "Valproic acid inhibits adhesion of vincristine- and cisplatin-resistant
RT   neuroblastoma tumour cells to endothelium.";
RL   Br. J. Cancer 96:1699-1706(2007).
//
RX   PubMed=31581737; DOI=10.3390/cells8101194; PMCID=PMC6830094;
RA   Povey, Jane F.
RA   Saintas, Emily
RA   Aderemi, Adewale Victor
RA   Rothweiler, Florian
RA   Zehner, Richard
RA   Dirks, Wilhelm Gerhard
RA   Cinatl, Jindrich Jr.
RA   Racher, Andrew J.
RA   Wass, Mark N.
RA   Smales, Christopher Mark
RA   Michaelis, Martin
RT   "Intact-cell MALDI-ToF mass spectrometry for the authentication of
RT   drug-adapted cancer cell lines.";
RL   Cells 8:1194.1-1194.12(2019).
//
RX   PubMed=24466371; DOI=10.1593/tlo.13544; PMCID=PMC3890703;
RA   Loschmann, Nadine
RA   Michaelis, Martin
RA   Rothweiler, Florian
RA   Zehner, Richard
RA   Cinatl, Jaroslaw
RA   Voges, Yvonne
RA   Sharifi, Mohsen
RA   Riecken, Kristoffer
RA   Meyer, Jochen
RA   von Deimling, Andreas
RA   Fichtner, Iduna
RA   Ghafourian, Taravat
RA   Westermann, Frank
RA   Cinatl, Jindrich Jr.
RT   "Testing of SNS-032 in a panel of human neuroblastoma cell lines with
RT   acquired resistance to a broad range of drugs.";
RL   Transl. Oncol. 6:685-696(2013).
//
RX   PubMed=27517323; DOI=10.18632/oncotarget.11160; PMCID=PMC5295411;
RA   Loschmann, Nadine
RA   Michaelis, Martin
RA   Rothweiler, Florian
RA   Voges, Yvonne
RA   Balonova, Barbora
RA   Blight, Barry A.
RA   Cinatl, Jindrich Jr.
RT   "ABCB1 as predominant resistance mechanism in cells with acquired
RT   SNS-032 resistance.";
RL   Oncotarget 7:58051-58064(2016).
//